inventivapharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Home - Inventiva
Description Focus About Inventiva Leadership Board of Directors Scientific Advisory Board Career Therapeutic Areas Non-alcoholic steatohepatitis (NASH) Mucopolysaccharidosi
Keywords N/A
Server Information
WebSite inventivapharma faviconinventivapharma.com
Host IP 217.160.0.25
Location Germany
Related Websites
Site Rank
More to Explore
ipphone-warehouse.com
ipsmf.org
irresistiblescents.co.uk
islamiinsurance.com
it.com.sg
itsmycargo.com
jainbiodata.com
japfu.top
jaycassario.com
jbrdigital.com
jiclbd.com
jollifyfashion.com
jotwani.com
journalfact.com
jrhu.com
jsnbooks.com
jufey.com
juheetravel.com
justforbaby.co
kacevalves.com
inventivapharma.com Valuation
US$5,946,489
Last updated: 2023-04-28 12:36:35

inventivapharma.com has Semrush global rank of 1,779,925. inventivapharma.com has an estimated worth of US$ 5,946,489, based on its estimated Ads revenue. inventivapharma.com receives approximately 686,134 unique visitors each day. Its web server is located in Germany, with IP address 217.160.0.25. According to SiteAdvisor, inventivapharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$5,946,489
Daily Ads Revenue US$5,490
Monthly Ads Revenue US$164,672
Yearly Ads Revenue US$1,976,064
Daily Unique Visitors 45,743
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
inventivapharma.com. A 597 IP: 217.160.0.25
inventivapharma.com. AAAA 597 IPV6: 2001:8d8:100f:f000::2b6
inventivapharma.com. NS 600 NS Record: dns104.ovh.net.
inventivapharma.com. NS 600 NS Record: ns104.ovh.net.
inventivapharma.com. MX 600 MX Record: 5 mib.inventivapharma.com.
inventivapharma.com. TXT 600 TXT Record: QuoVadis=19643bc2-d5a6-4ce3-ae9a-95f5e6270c5b
inventivapharma.com. TXT 600 TXT Record: QuoVadis=1cd26a36-8f0f-45ef-a40c-4969a34700f9
inventivapharma.com. TXT 600 TXT Record: v=spf1 ip4:5.149.186.86 ip4:5.149.186.83 ip4:5.149.186.84 mx -all
inventivapharma.com. TXT 600 TXT Record: google-site-verification=CRJbJqodRxLzwjlo8ggdLVi2Vr1BngaQm157ep27ISU
inventivapharma.com. TXT 600 TXT Record: zone-ownership-verification-eb40b4262d867fe4712dc46f5a50dc0d32b9a90a5b631e5a31f56faa91c06642
HtmlToTextCheckTime:2023-04-28 12:36:35
About Inventiva Leadership Board of Directors Scientific Advisory Board Career Therapeutic Areas Non-alcoholic steatohepatitis (NASH) Mucopolysaccharidosis (MPS) Publications PanNASH Initiative Pipeline Lanifibranor Odiparcil YAP-TEAD Clinical Trials Inventiva Expanded Access Policy Investors Corporate Governance Leadership Board of Directors Committee Composition Corporate governance documents Financial Calendar Results & Presentations Investor Presentations Regulated Information Shareholder Meetings Stock Market Data Stock Quote – Euronext Paris Stock Chart – Euronext Paris Stock Quote – NASDAQ Historic Price Lookup Investment Calculator SEC Filings Share Information Analyst Coverage Investor Resources IR Contacts Shareholder newsletter News & Events Contact Us We are Inventiva We develop novel and differentiated oral small molecule therapies for patients suffering from diseases with significant unmet medical need About Inventiva Breakthrough Solutions We develop drug candidates for
HTTP Headers
HTTP/1.1 301 Moved Permanently
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
Keep-Alive: timeout=15
Date: Thu, 21 Oct 2021 13:17:20 GMT
Server: Apache
X-Powered-By: W3 Total Cache/2.1.8
Expires: Thu, 21 Oct 2021 14:17:21 GMT
Cache-Control: max-age=3600
X-Redirect-By: WordPress
Location: https://inventivapharma.com/

HTTP/2 200 
content-type: text/html; charset=UTF-8
date: Thu, 21 Oct 2021 13:17:21 GMT
server: Apache
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink, ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
expires: Thu, 21 Oct 2021 13:57:58 GMT
pragma: public
cache-control: max-age=2437, public
x-powered-by: W3 Total Cache/2.1.8
last-modified: Thu, 21 Oct 2021 12:57:58 GMT
etag: "6b3907e550dc41906737db61eec75101"
inventivapharma.com Whois Information
Domain Name: INVENTIVAPHARMA.COM
Registry Domain ID: 1684977207_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ovh.com
Registrar URL: http://www.ovh.com
Updated Date: 2021-07-06T17:56:06Z
Creation Date: 2011-10-31T16:36:23Z
Registry Expiry Date: 2021-10-31T16:36:23Z
Registrar: OVH sas
Registrar IANA ID: 433
Registrar Abuse Contact Email: abuse@ovh.net
Registrar Abuse Contact Phone: +33.972101007
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS104.OVH.NET
Name Server: NS104.OVH.NET
DNSSEC: signedDelegation
DNSSEC DS Data: 2680 8 2 46AD59ACCD1FFFC418ACDB15949955F2A3DA84A1AF6C5A67A5740C69264357BB
>>> Last update of whois database: 2021-09-10T07:05:38Z <<<